🇺🇸 FDA
Patent

US 11980637

Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy

granted A61KA61K31/675A61K33/00

Quick answer

US patent 11980637 (Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy) held by United Kingdom Research and Innovation expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Kingdom Research and Innovation
Grant date
Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/675, A61K33/00, A61K9/14, A61P